logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – Carboplatin+paclitaxel hailed as new standard of care for advanced anal cancer

International group reports results from the first randomised controlled trial in this rare advanced cancer